Enzolytics Inc (ENZC)

[God_Father]

Folks are clearly missing how BIG this information is. You don't capture the attention of Ronald Moss' caliber, let alone join your board, if your company has nothing going on.

Folks have not even uncovered his ties to Dr. Fauci yet and what that means in terms of expediting our offering. I've been calling this for weeks and predicted this high caliber board to join us.

Mark my words carefully. Millionaires will be made here if they are willing to hold.

Best of luck.





5.11/10/2020 We know they were meeting with a GMP Manufacturer by the end of the Monday and what do you know Ronald Moss MD comes on board as Medical Advisor. Just so your know here is his salary last year at the Company he is Chief Medical officer for . Adamis Pharmaceuticals.
Ronald Moss Net Worth

The estimated Net Worth of Ronald B. Moss is at least $1.56 Million dollars as of 18 August 2020. . In addition, he makes $1,339,550 as Chief Medical Officer at Adamis Pharmaceuticals.
--
6. So Ronald Comes on to the MEDICAL ADVISORY BOARD, while still being Chief Medical Officer at Adamis. Wonder why he is making per Month the rate of $111,629.00 , not to shabby !!!
lets see what does Ronald specialize in https://www.linkedin.com/in/ronald-moss-18130212/
Quote
I trained in the Laboratory of Clinical Investigation at the National Institute of Allergy and Infectious Disease, National Institutes of Health. I have been involved in clinical trials and Company leadership for over thirty years. I am also a practicing physician. I have been fortunate to successfully work with KOL's including the late Dr. Jonas Salk. I have worked closely with FDA, WHO, CDC, and NIH. My focus has always been about the patient and evidenced based therapeutics and vaccines that advances public health.

My experience includes the execution of successful phase 1-3 trials in both pediatric and adult populations in the U.S. , Europe, Asia, Africa, and South America. I have been involved in multiple phase 1, phase 2 and phase 3 clinical trials including preventative and therapeutic vaccines, biologics, small molecules for COVID19. rheumatoid arthritis, asthma, multiple sclerosis, CMV, HIV, anaphylaxis and antivirals (influenza and parainfluenza). I have also been the lead for two successful vaccine BLA’s and two successful NDA's. I have led advisory panel meeting with both the FDA and EMEA. I have been involved in FAST Track, Orphan and Breakthrough Designations. As a physician I have a unique understanding of science, clinical niches, clinical operations, and regulatory strategy.

I am an author of over 100 peer reviewed publications and has given hundreds of presentations at key scientific and regulatory meetings. My publications include co-authors include the late Jonas Salk and Robert Gallo. I have held major management positions in biotechnology and pharmaceutical companies and has been involved with executing successful partnerships and fund raising including experience as a CEO and CMO. I have successfully completed private and public equity raises including NIH and BARDA funding.